How old is Mark Bresnik?
Mark Bresnik is possibly 75 years old and maybe was born in April 1951.
Next Steps: Find a result that matches whom you're looking for the most. Once you find a match, click "Search For Background Reports" to continue. Or use the form below to find the person you are searching for.
By clicking “SEARCH” I agree to the current USSearch TERMS OF USE and PRIVACY POLICY, and agree not use the products or services of USSearch to determine one's eligibility for credit, housing, insurance, employment or any other reason subject to the Fair Credit Reporting Act (“FCRA”). I further understand that USSearch is not a “consumer reporting agency” and does not provide “consumer reports” under the FCRA.
We have 4 records for Mark Bresnik with an approximate age of 75 years old. Mark has been found in 2 states including California and Washington. On file we have 9 email addresses. And 12 phone numbers linked to Mark, with area codes such as 360, 415, 505, 510 and 561, and 2 other area codes. The information below may also include images, social media accounts and more.
AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):
mobile
new cingular wireless pcs llc (at&t mobility)
landline
bellsouth telecommunications inc dba southern bell telephone & telegraph (at&t southeast)
First Reported July 12, 2014
112 La Quinta St
Moraga, California 94556
Contra Costa
Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Bresnik.
Mark Bresnik
Co-founder and Infectious Diseases Consultant
East Bay Aids Center-ebac
Mark Bresnik
Director, Clinical Research | Lead Forambisome (liposomal Amphotericinb; Invasive Fungal Infections)
Gilead Sciences
Mark Bresnik
Director, Clinical Research | for Cidecin (daptomycin; Resistant Gram Positive Bacterial Infections)
Gilead Sciences
Mark Bresnik
Director, Clinical Research | for Hepsera (adefovir; Hepatitis B)
Gilead Sciences
Mark Bresnik
Executive Director, Clinical R&d
F2g
Mark Bresnik
General Internal Medicine Physician
East Bay Internal Medicine
Mark Bresnik
Guest Lecturer (graduate / Undergraduate)
University of California, Berkeley | School of Public Health
Mark Bresnik
Guest Lecturer (school of Public Health, Uc-berkeley-ucsf Joint Medical Program)
University of California, Berkeley | School of Public Health
Mark Bresnik
Infectious Diseases Consultant
Bay Infectious Diseases Medical Group
Mark Bresnik
Infectious Diseases Consultant
Mb-id Consulting
Mark Bresnik
Internal Medicine Hospitalist
Alta Bates Summit Medical Center
Mark Bresnik
Medical Director, Infection Control | Hospital Epidemiology
Alta Bates Summit Medical Center
Mark Bresnik
Medical Director, Infectious Diseases – Antibiotic Review Team (antibiotic Stewardship)
Alta Bates Summit Medical Center
Mark Bresnik
Medical Director, Microbiology Laboratory
Alta Bates Summit Medical Center
Mark Bresnik
Sr. Director, Clinical Research | Advisor to Ambisome Clin Research, Med Affairs, & Regulatory Teams
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | Case Reviewer Remdesivir (covid-19 Compassionate Use Program)
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | Cayston (aztreonam Lysine; Cystic Fibrosis, Non-cf Bronchiectasis)
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | Lead for Tirabrutinib (inflammation/rheumatoid Arthritis)
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | for Filgotinib (inflammation/rheumatoid Arthritis)
Gilead Sciences
Mark Bresnik
Staff Physician
Alta Bates Summit Medical Center
AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):
mobile
new cingular wireless pcs llc (at&t mobility)
mobile
new cingular wireless pcs llc (at&t mobility)
66 Vicente Rd
Berkeley, California 94705
Alameda
Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Bresnik.
Mark Bresnik
Co-founder and Infectious Diseases Consultant
East Bay Aids Center-ebac
Mark Bresnik
Director, Clinical Research | Lead Forambisome (liposomal Amphotericinb; Invasive Fungal Infections)
Gilead Sciences
Mark Bresnik
Director, Clinical Research | for Cidecin (daptomycin; Resistant Gram Positive Bacterial Infections)
Gilead Sciences
Mark Bresnik
Director, Clinical Research | for Hepsera (adefovir; Hepatitis B)
Gilead Sciences
Mark Bresnik
Executive Director, Clinical R&d
F2g
Mark Bresnik
General Internal Medicine Physician
East Bay Internal Medicine
Mark Bresnik
Guest Lecturer (graduate / Undergraduate)
University of California, Berkeley | School of Public Health
Mark Bresnik
Guest Lecturer (school of Public Health, Uc-berkeley-ucsf Joint Medical Program)
University of California, Berkeley | School of Public Health
Mark Bresnik
Infectious Diseases Consultant
Bay Infectious Diseases Medical Group
Mark Bresnik
Infectious Diseases Consultant
Mb-id Consulting
Mark Bresnik
Internal Medicine Hospitalist
Alta Bates Summit Medical Center
Mark Bresnik
Medical Director, Infection Control | Hospital Epidemiology
Alta Bates Summit Medical Center
Mark Bresnik
Medical Director, Infectious Diseases – Antibiotic Review Team (antibiotic Stewardship)
Alta Bates Summit Medical Center
Mark Bresnik
Medical Director, Microbiology Laboratory
Alta Bates Summit Medical Center
Mark Bresnik
Sr. Director, Clinical Research | Advisor to Ambisome Clin Research, Med Affairs, & Regulatory Teams
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | Case Reviewer Remdesivir (covid-19 Compassionate Use Program)
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | Cayston (aztreonam Lysine; Cystic Fibrosis, Non-cf Bronchiectasis)
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | Lead for Tirabrutinib (inflammation/rheumatoid Arthritis)
Gilead Sciences
Mark Bresnik
Sr. Director, Clinical Research | for Filgotinib (inflammation/rheumatoid Arthritis)
Gilead Sciences
Mark Bresnik
Staff Physician
Alta Bates Summit Medical Center
mobile
new cingular wireless pcs llc (at&t mobility)
First Reported January 13, 2015
mobile
new cingular wireless pcs llc (at&t mobility)
First Reported December 06, 2009
1010 2nd St Apt 236
Lafayette, California 94549
Contra Costa
708 Nw 60th St
Seattle, Washington 98107
King
Click here to search for background reports.
Mark Bresnik is possibly 75 years old and maybe was born in April 1951.
Mark Bresnik has been associated with 4 addresses, the last known one is 112 La Quinta St, Moraga, Ca 94556-1025.
Mark Bresnik has been known to have 15 phone numbers, including (650) 996-7013.
Mark Bresnik has been known to have 20 email addresses, including xxxxxx@aol.com.
Mark Bresnik's possible relatives include Cynthia Kay Bloebaum, Janis Ruth Bloebaum, Andrew Scott Bresnik and others.
Mark Bresnik could be an Executive Director, Clinical R&d at F2g and might have 20 other jobs on file.
Mark Bresnik could of attended University Of Illinois College Of Medicine where Mark Bresnik received a degree in Doctor Of Medicine (md).
Mark Bresnik could have a professional license, including an expired physician assistant supervisor license in CA
Search by First Name
Search by Last Name